['asthma']
['symbicort pmdi', 'symbicort pmdi']

        Inclusion Criteria:

          -  Has a documented clinical diagnosis of asthma defined by the ATS for at least 6 months
             prior to Visit 2

          -  Have a morning pre-bronchodilator clinic FEV1 measured at least 6 hours after the last
             dose of inhaled SABA and at least 48 hours after last dose of inhaled LABA of 60% to
             100% of predicted normal

          -  Demonstrated reversibility of clinic FEV1 of ≥12% from pre -albuterol/salbutamol level
             within 15 to 30 minutes after administration of a standard dose of
             albuterol/salbutamol.

        Exclusion Criteria:

          -  Have been hospitalized at least once or required emergency treatment more than once
             for an asthma-related condition during the 6 months prior to Visit 1

          -  Have required treatment with systemic corticosteroids (eg, oral, parenteral, or
             rectal) for any reason within the 6 weeks prior to Visit 1
      